NO178371C - Ravsyreforbindelser - Google Patents

Ravsyreforbindelser

Info

Publication number
NO178371C
NO178371C NO921200A NO921200A NO178371C NO 178371 C NO178371 C NO 178371C NO 921200 A NO921200 A NO 921200A NO 921200 A NO921200 A NO 921200A NO 178371 C NO178371 C NO 178371C
Authority
NO
Norway
Prior art keywords
group
isomers
carbon atoms
atom
lower alkyl
Prior art date
Application number
NO921200A
Other languages
English (en)
Other versions
NO921200L (no
NO921200D0 (no
NO178371B (no
Inventor
Nobuyuki Tanaka
Masaru Saito
Kenji Akahane
Fumiyasu Sato
Atsushi Tsubaki
Hiroshi Hokari
Michihiro Kobayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3142275A external-priority patent/JP2686861B2/ja
Priority claimed from JP3188416A external-priority patent/JP2686863B2/ja
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO921200D0 publication Critical patent/NO921200D0/no
Publication of NO921200L publication Critical patent/NO921200L/no
Publication of NO178371B publication Critical patent/NO178371B/no
Publication of NO178371C publication Critical patent/NO178371C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/06Preparatory processes
    • C08G77/08Preparatory processes characterised by the catalysts used
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Polymers (AREA)
NO921200A 1991-03-30 1992-03-27 Ravsyreforbindelser NO178371C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3142275A JP2686861B2 (ja) 1991-03-30 1991-03-30 新規なベンジリデンコハク酸誘導体
JP3188416A JP2686863B2 (ja) 1991-04-25 1991-04-25 新規なベンジルコハク酸誘導体
JP36151991 1991-12-27

Publications (4)

Publication Number Publication Date
NO921200D0 NO921200D0 (no) 1992-03-27
NO921200L NO921200L (no) 1992-10-01
NO178371B NO178371B (no) 1995-12-04
NO178371C true NO178371C (no) 1996-03-13

Family

ID=27318415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921200A NO178371C (no) 1991-03-30 1992-03-27 Ravsyreforbindelser

Country Status (12)

Country Link
US (1) US5202335A (no)
EP (1) EP0507534B1 (no)
KR (1) KR100192530B1 (no)
AT (1) ATE134615T1 (no)
AU (1) AU654331B2 (no)
CA (1) CA2062877C (no)
DE (1) DE69208496T2 (no)
DK (1) DK170973B1 (no)
ES (1) ES2084275T3 (no)
FI (1) FI102172B1 (no)
HK (1) HK1005449A1 (no)
NO (1) NO178371C (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0967204A4 (en) * 1997-01-29 2000-11-29 Kissei Pharmaceutical METHOD FOR THE PRODUCTION OF BENZYL succinic acid ester derivatives
FR2765578B1 (fr) * 1997-07-03 1999-09-10 Adir Procede de preparation d'un perhydroisoindole substitue
JP3277320B2 (ja) * 1997-08-28 2002-04-22 有機合成薬品工業株式会社 シス−ヘキサヒドロイソインドリン誘導体の製造方法
FR2777566B1 (fr) * 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2779428B1 (fr) * 1998-06-03 2001-05-18 Synthelabo Derives d'oxo-azacycloalcanes, leurs preparations et leurs applications en therapeutique
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
FR2793411B1 (fr) * 1999-05-11 2001-06-29 Synthelabo Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation
US7166301B1 (en) * 1999-05-21 2007-01-23 Kissei Pharmaceutical Co., Ltd. Immediate release medicinal compositions for oral use
PE20020617A1 (es) 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
KR20020092060A (ko) * 2001-06-01 2002-12-11 김정균 알콕시 작용성 그룹을 포함한 폴리실록산 화합물
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CA2565878A1 (en) * 2004-05-11 2005-11-17 Kissei Pharmaceutical Co., Ltd. Pharmaceutical composition for prevention or treatment of lipid metabolism disorder
WO2006003907A1 (ja) * 2004-07-01 2006-01-12 Kissei Pharmaceutical Co., Ltd. 血管内膜過増殖疾患の予防または治療剤
JP2008514549A (ja) * 2004-09-14 2008-05-08 エリクシアー ファーマシューティカルズ, インコーポレイテッド 制御された炭水化物消化のための併用療法
CN1634885B (zh) * 2004-11-09 2011-05-04 北京乐力健生物科技有限公司 米格列奈晶型及其制备方法
CN1324010C (zh) * 2005-01-12 2007-07-04 江苏省药物研究所 一种米格列奈的制备方法
KR20070102694A (ko) * 2005-01-31 2007-10-19 아지노모토 가부시키가이샤 혈당 강하제를 함유하는, 내당능 이상, 경계형 당뇨병,인슐린 저항성 및 고인슐린혈증 개선 또는 치료용 의약조성물
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
AU2006311601A1 (en) * 2005-11-07 2007-05-18 Elixir Pharmaceuticals, Inc. Combinations of metformin and meglitinide
WO2009047797A2 (en) * 2007-10-08 2009-04-16 Ind-Swift Laboratories Limited Process for the preparation of perhydroisoindole derivative
KR20110074614A (ko) * 2009-03-19 2011-06-30 고쿠리츠 다이가쿠 호진 교토 다이가쿠 췌도 이미징용 분자 프로브 전구체 및 그 사용
SI2429995T1 (sl) 2009-05-15 2014-05-30 Novartis Ag Arilpiridini kot inhibitorji aldosteron sintaze
BRPI1012852A2 (pt) 2009-05-15 2018-06-19 Novartis Ag derivados de benzoxazolona como inibidores da sintase de aldoesterona
NZ596304A (en) 2009-05-28 2014-01-31 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
EP2435402B1 (en) 2009-05-28 2016-04-13 Novartis AG Substituted aminobutyric derivatives as neprilysin inhibitors
EP2993169B1 (en) 2009-11-17 2017-12-20 Novartis AG Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8575160B2 (en) 2009-11-30 2013-11-05 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
CN101973926B (zh) * 2010-11-05 2012-09-19 威海迪素制药有限公司 R-米格列奈钙的制备方法
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
WO2013189829A1 (en) 2012-06-22 2013-12-27 Laboratorios Lesvi, S. L. Process for obtaining (s)-2-benzyl-4-((3ar,7as)-hexahydro-1 h-isoindol- 2(3h)-yl)-4-oxobutanoic acid and salts thereof
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
LT2956464T (lt) 2013-02-14 2018-07-10 Novartis Ag Pakeisti bisfenilbutanoinės fosfonrūgšties dariniai, kaip nep (neutralios endopeptidazės) inhibitoriai
MX2016001021A (es) 2013-07-25 2016-08-03 Novartis Ag Bioconjugados de polipeptidos de apelina sinteticos.
KR20160031551A (ko) 2013-07-25 2016-03-22 노파르티스 아게 심부전의 치료를 위한 시클릭 폴리펩티드
SG11201704758XA (en) 2015-01-23 2017-08-30 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
CN106631978B (zh) * 2016-12-29 2020-03-24 千辉药业(安徽)有限责任公司 一种米格列奈中间体的合成工艺
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3689506D1 (de) * 1985-10-09 1994-02-17 Shell Int Research Neue Acrylsäureamide.
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DK41592D0 (da) 1992-03-27
NO921200L (no) 1992-10-01
US5202335A (en) 1993-04-13
DE69208496D1 (de) 1996-04-04
DE69208496T2 (de) 1996-10-17
ES2084275T3 (es) 1996-05-01
FI921392A (fi) 1992-10-01
ATE134615T1 (de) 1996-03-15
FI102172B (fi) 1998-10-30
DK41592A (da) 1992-10-01
AU1280992A (en) 1992-10-01
DK170973B1 (da) 1996-04-09
HK1005449A1 (en) 1999-01-08
CA2062877C (en) 2002-07-02
CA2062877A1 (en) 1992-10-01
KR100192530B1 (ko) 1999-06-15
KR930019682A (ko) 1993-10-18
EP0507534A1 (en) 1992-10-07
NO921200D0 (no) 1992-03-27
NO178371B (no) 1995-12-04
FI921392A0 (fi) 1992-03-30
FI102172B1 (fi) 1998-10-30
EP0507534B1 (en) 1996-02-28
AU654331B2 (en) 1994-11-03

Similar Documents

Publication Publication Date Title
FI921392A (fi) Baernstensyrafoereningar
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
HK1032969A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
TW370451B (en) Bicyclic amine derivatives
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
AU7127794A (en) 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands
KR890001989A (ko) 펜타디엔아미드
EP0312269A3 (en) 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as h3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents ypocholesterolemic agents
HU9302395D0 (en) Method for producing 4-/(benzothiazolyl)-methyl-amino/-alpha-/(3,4-difluorine-phenoxi)-methyl/-1-piperidine-ethanol
RU94037965A (ru) Производные бензоксазола в виде рацемата или отдельных энантиомеров и их фармацевтически приемлемые соли и фармацевтические композиции с ингибирующей биосинтез лейкотриенов активностью
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
NO169837C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive forbindelser
DE69006607D1 (de) Verfahren zur Herstellung von Carbamaten und dabei auftretende Zwischenprodukte.
ATE223406T1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
AU4574900A (en) Use of succinic acid derivatives to obtain a medicine for treating inflammation